Regulatory roles and mechanisms of alternative RNA splicing in adipogenesis and human metabolic health
Alternative splicing (AS) regulates gene expression patterns at the post-transcriptional level and generates a striking expansion of coding capacities of genomes and cellular protein diversity. RNA splicing could undergo modulation and close interaction with genetic and epigenetic machinery. Notably, during the adipogenesis processes of white, brown and beige adipocytes, AS tightly interplays with the differentiation gene program networks. Here, we integrate the available findings on specific splicing events and distinct functions of different splicing regulators as examples to highlight the directive biological contribution of AS mechanism in adipogenesis and adipocyte biology. Furthermore, accumulating evidence has suggested that mutations and/or altered expression in splicing regulators and aberrant splicing alterations in the obesity-associated genes are often linked to humans' diet-induced obesity and metabolic dysregulation phenotypes. Therefore, significant attempts have been finally made to overview novel detailed discussion on the prospects of splicing machinery with obesity and metabolic disorders to supply featured potential management mechanisms in clinical applicability for obesity treatment strategies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Cell & bioscience - 11(2021), 1 vom: 01. Apr., Seite 66 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chao, Yunqi [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adipogenesis |
---|
Anmerkungen: |
Date Revised 08.04.2021 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1186/s13578-021-00581-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM323505279 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM323505279 | ||
003 | DE-627 | ||
005 | 20231225184328.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s13578-021-00581-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1078.xml |
035 | |a (DE-627)NLM323505279 | ||
035 | |a (NLM)33795017 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chao, Yunqi |e verfasserin |4 aut | |
245 | 1 | 0 | |a Regulatory roles and mechanisms of alternative RNA splicing in adipogenesis and human metabolic health |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 08.04.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Alternative splicing (AS) regulates gene expression patterns at the post-transcriptional level and generates a striking expansion of coding capacities of genomes and cellular protein diversity. RNA splicing could undergo modulation and close interaction with genetic and epigenetic machinery. Notably, during the adipogenesis processes of white, brown and beige adipocytes, AS tightly interplays with the differentiation gene program networks. Here, we integrate the available findings on specific splicing events and distinct functions of different splicing regulators as examples to highlight the directive biological contribution of AS mechanism in adipogenesis and adipocyte biology. Furthermore, accumulating evidence has suggested that mutations and/or altered expression in splicing regulators and aberrant splicing alterations in the obesity-associated genes are often linked to humans' diet-induced obesity and metabolic dysregulation phenotypes. Therefore, significant attempts have been finally made to overview novel detailed discussion on the prospects of splicing machinery with obesity and metabolic disorders to supply featured potential management mechanisms in clinical applicability for obesity treatment strategies | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Adipogenesis | |
650 | 4 | |a Alternative splicing | |
650 | 4 | |a Metabolic disorders | |
650 | 4 | |a Obesity | |
650 | 4 | |a Splicing factor | |
700 | 1 | |a Jiang, Yonghui |e verfasserin |4 aut | |
700 | 1 | |a Zhong, Mianling |e verfasserin |4 aut | |
700 | 1 | |a Wei, Kaiyan |e verfasserin |4 aut | |
700 | 1 | |a Hu, Chenxi |e verfasserin |4 aut | |
700 | 1 | |a Qin, Yifang |e verfasserin |4 aut | |
700 | 1 | |a Zuo, Yiming |e verfasserin |4 aut | |
700 | 1 | |a Yang, Lili |e verfasserin |4 aut | |
700 | 1 | |a Shen, Zheng |e verfasserin |4 aut | |
700 | 1 | |a Zou, Chaochun |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cell & bioscience |d 2011 |g 11(2021), 1 vom: 01. Apr., Seite 66 |w (DE-627)NLM209533447 |x 2045-3701 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2021 |g number:1 |g day:01 |g month:04 |g pages:66 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13578-021-00581-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2021 |e 1 |b 01 |c 04 |h 66 |